Kovina Therapeutics operates as a pre-clinical biotechnology company.
Kovina Therapeutics operates as a pre-clinical biotechnology company aims to discover a non-surgical, medical treatment for Human Papillomavirus (HPV) infections and cancers.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 1, 2022 | Grant | $275K | 1 |
National Institute of Dental and Craniofacial Research (NIDCR)
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institute of Dental and Craniofacial Research (NIDCR)
|
Yes | Grant |